{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:51:33Z","timestamp":1779943893460,"version":"3.53.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ijantimicag.2013.07.018","type":"journal-article","created":{"date-parts":[[2013,9,7]],"date-time":"2013-09-07T16:02:15Z","timestamp":1378569735000},"page":"403-409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli in patients with cancer"],"prefix":"10.1016","volume":"42","author":[{"given":"Young Eun","family":"Ha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol-In","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Kyeong","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Yeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Mi","family":"Wi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doo Ryeon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong Ran","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hoon","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0005","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00520-010-1017-4","article-title":"Clinical factors predicting bacteremia in low-risk febrile neutropenia after anti-cancer chemotherapy","volume":"19","author":"Ha","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/649537","article-title":"Spanish Network for Research in Infectious Diseases (REIPI), Community-onset bacteremia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli: risk factors and prognosis","volume":"50","author":"Rodr\u00edguez-Ba\u00f1o","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: an emerging public-health concern","volume":"8","author":"Pitout","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0020","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/604713","article-title":"A multinational survey of risk factors for infection with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in nonhospitalized patients","volume":"49","author":"Ben-Ami","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","article-title":"Combination antibiotic therapy versus monotherapy for Gram-negative bacteraemia: a commentary","volume":"11","author":"Chow","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0035","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0040","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Document M100-S21. Wayne, PA: CLSI; 2011."},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.femsle.2005.02.029","article-title":"CTX-M and SHV-12 \u03b2-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea","volume":"245","author":"Kim","year":"2005","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0050","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1128\/JCM.02065-07","article-title":"Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing","volume":"46","author":"Lau","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00277-011-1247-7","article-title":"Risk factors for infection and treatment outcome of extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy","volume":"91","author":"Kang","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0060","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jinf.2009.02.002","article-title":"Incidence and clinical impact of extended-spectrum-\u03b2-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies","volume":"58","author":"Trecarichi","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0065","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/jac\/dkq494","article-title":"Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes","volume":"66","author":"Gudiol","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0070","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10096-010-1093-x","article-title":"Risk factors for, and clinical relevance of, faecal extended-spectrum \u03b2-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies","volume":"30","author":"Arnan","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0075","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/dkp411","article-title":"Bacteraemia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome","volume":"65","author":"Gudiol","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0080","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/mdr.2010.0134","article-title":"Epidemiology and clinical features of community-onset bacteremia caused by extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae","volume":"17","author":"Lee","year":"2011","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0085","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkm318","article-title":"Mortality and delay in effective therapy associated with extended-spectrum \u03b2-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis","volume":"60","author":"Schwaber","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/00365548.2012.730151","article-title":"Clinical impact of inappropriate initial antimicrobial therapy on outcome in bacteremic biliary tract infections","volume":"45","author":"Kang","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0095","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.diagmicrobio.2004.11.014","article-title":"Production of C-reactive protein in Escherichia coli-infected patients with liver dysfunction due to liver cirrhosis","volume":"51","author":"Park","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0100","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1183\/09031936.05.00071704","article-title":"C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study","volume":"25","author":"Povoa","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0105","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ijantimicag.2010.05.009","article-title":"Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli","volume":"36","author":"Kang","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0110","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1128\/AAC.00247-09","article-title":"Molecular characteristics of extended-spectrum-\u03b2-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections","volume":"53","author":"Pitout","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0115","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/508877","article-title":"Bacteremia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge","volume":"43","author":"Rodr\u00edguez-Ba\u00f1o","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0120","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/archinte.168.17.1897","article-title":"Community infections caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli","volume":"168","author":"Rodr\u00edguez-Bano","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0125","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1086\/500936","article-title":"Influx of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae into the hospital","volume":"42","author":"Ben-Ami","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0130","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jinf.2009.11.004","article-title":"Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea","volume":"60","author":"Lee","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0135","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1128\/AAC.48.10.3758-3764.2004","article-title":"Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum \u03b2-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada","volume":"48","author":"Boyd","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.018_bib0140","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1128\/JCM.02353-09","article-title":"Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-\u03b2-lactamase-producing Escherichia coli","volume":"48","author":"Rodr\u00edguez-Ba\u00f1o","year":"2010","journal-title":"J Clin Microbiol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913002902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913002902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T04:57:53Z","timestamp":1539406673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857913002902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0924857913002902"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.07.018","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli in patients with cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}